Researchers at Oregon Health & Science University have found that treatment with sodium thiosulfate significantly reduces hearing loss in brain tumor patients receiving carboplatin chemotherapy. This breakthrough could help combat the hearing loss associated with platinum-based chemotherapy treatment for other types of cancer.
SourceOregon Health & Science University·JournalJournal of Pharmacology and Experimental Therapeutics·DateJul 7, 1998
A synthetic detergent, nonylphenolethoxylate (NPE), commonly used in household cleansers, has been discovered to block a drug pump in cancer cells, reducing the need for chemotherapy drugs. The researchers found NPE present in human urine and suggest it could be a useful adjunct to standard treatments.
Rigol DP832 Triple-Output Bench Power Supply
Rigol DP832 Triple-Output Bench Power Supply powers sensors, microcontrollers, and test circuits with programmable rails and stable outputs.
BioNumerik's novel chemoprotecting agent BNP7787 appears to completely protect against major toxicities associated with widely used platinum anticancer drugs. The company's Karenitecins demonstrate potent oral antitumor activity and bypass common drug resistance mechanisms.
Duke researchers have identified a lung condition in breast cancer patients that can limit therapy choices if not treated promptly. The disorder, DPTS, is successfully treated with inexpensive corticosteroids, improving pulmonary function by 17%.
SourceDuke University Medical Center·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateFeb 18, 1998
Researchers at St. Jude Children's Research Hospital are developing new brain tumor treatment protocols that use 3D imaging to accurately target tumors, reducing radiation doses and side effects. The protocols involve combining lower-dose radiation with chemotherapy to increase survival rates and minimize long-term damage.
SourceSt. Jude Children's Research Hospital·DateNov 5, 1997
Apple iPhone 17 Pro
Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.
The MiCK assay measures how light scatters off of leukemia cells to determine the effectiveness of drugs being used to attack the cells. This technique allows for more accurate identification of which drugs will be most effective for each patient, revolutionizing leukemia therapy.
Researchers developed a synthetic human hormone that triples platelets received from each donor, improving recovery of platelets in patients undergoing chemotherapy. An increased supply would give physicians more options for treating chemotherapy patients and make transfusions more affordable.
The study reveals that a low-dose pretreatment with certain DNA-crosslinking agents can temporarily suppress P-glycoprotein production, increasing the sensitivity of drug-resistant cells to chemotherapy. This approach may increase the efficacy of cancer chemotherapy in patients and minimize drug interactions.
SourceThe Geisel School of Medicine at Dartmouth·JournalClinical Cancer Research·DateAug 13, 1997
Researchers at University at Buffalo and Roswell Park Cancer Institute found no link between chemotherapy use and cancer risk in children's offspring. The study analyzed health records of 153 children born to 91 chemotherapy patients, showing none developed cancer.
SAMSUNG T9 Portable SSD 2TB
SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.
AmBisome, a liposomal formulation of amphotericin B, has been shown to sterilize the CSF significantly earlier than conventional amphotericin B, with at least equal clinical efficacy and lower nephrotoxicity. In a randomized multi-center study, low-dose AmBisome therapy produced a response rate of 68% in treating invasive aspergillosis.
Duke University researchers identify a new target for stopping drug resistance in cancer cells by targeting the cellular pump that expels chemotherapy drugs. The study found that certain immunosuppressive drugs can block this pump by removing a vital activator, FKBP12, allowing chemotherapy drugs to be effective.
Researchers at Georgia Institute of Technology have developed a new method to examine and quickly map how nucleic acid ligands bind to and alter DNA at the molecular level. This allows for direct visualization of individual DNA molecules, providing crucial information on drug binding and mode of action.
Scientists have detailed the structure of yeast topoisomerase II, a key player in cell division. This knowledge could lead to the development of new anticancer drugs that target this enzyme. The discovery also has implications for the design of antimicrobial drugs and the treatment of cancer.
SourceNIH/National Institute of General Medical Sciences·DateApr 29, 1996
Meta Quest 3 512GB
Meta Quest 3 512GB enables immersive mission planning, terrain rehearsal, and interactive STEM demos with high-resolution mixed-reality experiences.